Preventive Asthma Drug Market Outlook 2020
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Dec, 2015| No. of Pages : 45
1. Analyst View
2. Research Methodology
3. Asthma - An Introduction
4. Drivers & Challenges
4.1 Drivers
4.1.1 Rising Healthcare Expenditure
4.1.2 Growing Geriatric Population
4.1.3 Increasing Prevalence of Asthma
4.1.4 Increasing R&D Driving Innovation
4.2 Challenges
4.2.1 High Cost of Drugs
4.2.2 Side Effects Caused By Drugs
4.2.3 Limited Demand from Developing Markets
4.2.4 Inadequate Awareness
5. Preventive Asthma Drugs Market Overview
6. Market Segmentation
6.1 By Type of Drugs
6.2 By Geography
7. Trends & Developments
7.1 Combined Therapy Benefitting Asthma Patients
7.2 Monoclonal Antibody: An Emerging Effective Treatment for Asthma
7.3 Asthma Tracking Tool Aiding Disease Management 26
8. Competitive Assessment
8.1 Market Share of Key Players
8.2 Top Selling Preventive Asthma Drugs
8.3 Profiles
8.3.1 Glaxosmithkline
8.3.2 Astrazeneca
8.3.3 Merck
8.3.4 Roche
8.3.5 Novartis
9. Recommendations